The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Immunoglobulin M (human monoclonal HA-1A anti-endotoxin), disulfide with human monoclonal HA-1A kappa-chain, pentameric dimer (WHO)
- Nebacumabum (Latin)
- Nebacumab (German)
- Nebacumab (French)
- Nebacumab (Spanish)
- Nebacumab (OS: BAN, USAN)
- Nébacumab (OS: DCF)
- Antiendotoxin monoclonal antibody (IS)
- HA-1A (IS)
- Septomonab (IS)
- Xomen-E5 (IS)
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.